Abstract
Enterococci are Gram-positive facultative anaerobic bacteria that colonize the oral cavity and gastrointestinal tract. Enterococcal infections, mainly caused by Enterococcus faecalis and Enterococcus faecium, include apical periodontitis, endocarditis, and bloodstream infections. Recently, vancomycinresistant Enterococci are considered major pathogens that are common but difficult to treat, especially in nosocomial settings. Moreover, E. faecalis is closely associated with recurrent endodontic infections and failed endodontic treatment. In this study, we investigated the effects of short-chain fatty acids (SCFAs), acetate, propionate, and butyrate, which are metabolites fermented by gut microbiota, on the growth of Enterococci. Enterococci were cultured in the presence or absence of acetate, propionate, or butyrate, and the optical density at 600 nm was measured to determine bacterial growth. The minimum inhibitory concentration/minimum bactericidal concentration test was conducted. Bacteria were treated with a SCFA, together with clinically used endodontic treatment methods such as triple antibiotics (metronidazole, minocycline, and ciprofloxacin) and chlorhexidine gluconate (CHX) to determine the effects of combination treatment. Of the SCFAs, propionate had a bacteriostatic effect, inhibiting the growth of E. faecalis in a dose-dependent manner and also that of clinical strains of E. faecalis isolated from dental plaques. Meanwhile, acetate and butyrate had minimal effects on E. faecalis growth. Moreover, propionate inhibited the growth of other Enterococci including E. faecium. In addition, combination treatment of propionate and triple antibiotics led to further growth inhibition, whereas no cooperative effect was observed at propionate plus CHX. These results indicate that propionate attenuates the growth of Enterococci, suggesting propionate as a potential agent to control Enterococcal infections, especially when combined with triple antibiotics.
Similar content being viewed by others
References
Arias, C.A. and Murray, B.E. 2012. The rise of the Enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 10, 266–278.
Babich, H., Wurzburger, B.J., Rubin, Y.L., Sinensky, M.C., and Blau, L. 1995. An in vitro study on the cytotoxicity of chlorhexidine digluconate to human gingival cells. Cell. Biol. Toxicol. 11, 79–88.
Brock, M. and Buckel, W. 2004. On the mechanism of action of the antifungal agent propionate. Eur. J. Biochem. 271, 3227–3241.
Cetinkaya, Y., Falk, P., and Mayhall, C.G. 2000. Vancomycin-resistant Enterococci. Clin. Microbiol. Rev. 13, 686–707.
CLSI. 2012. Tests for bacteria that grow aerobically; approved standard — ninth edition. CLSI Document M07-A9. CLSI, Wayne, PA, USA.
Cummings, J.H., Pomare, E.W., Branch, W.J., Naylor, C.P., and Macfarlane, G.T. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227.
Dolan, S.K., Wijaya, A., Geddis, S.M., Spring, D.R., Silva-Rocha, R., and Welch, M. 2018. Loving the poison: The methylcitrate cycle and bacterial pathogenesis. Microbiology 164, 251–259.
Evans, M., Davies, J.K., Sundqvist, G., and Figdor, D. 2002. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int. Endod. J. 35, 221–228.
Gentry-Weeks, C.R., Karkhoff-Schweizer, R., Pikis, A., Estay, M., and Keith, J.M. 1999. Survival of Enterococcus faecalis in mouse peritoneal macrophages. Infect. Immun. 67, 2160–2165.
Gu, Y.H., Yamasita, T., and Kang, K.M. 2018. Subchronic oral dose toxicity study of Enterococcus faecalis 2001 (ef 2001) in mice. Toxicol. Res. 34, 55–63.
Hancock, H.H. 3rd, Sigurdsson, A., Trope, M., and Moiseiwitsch, J. 2001. Bacteria isolated after unsuccessful endodontic treatment in a North American population. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91, 579–586.
Hebert, L., Courtin, P., Torelli, R., Sanguinetti, M., Chapot-Chartier, M.P., Auffray, Y., and Benachour, A. 2007. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance. Infect. Immun. 75, 5390–5398.
Jacobson, A., Lam, L., Rajendram, M., Tamburini, F., Honeycutt, J., Pham, T., Van Treuren, W., Pruss, K., Stabler, S.R., Lugo, K., et al. 2018. A gut commensal-produced metabolite mediates colonization resistance to salmonella infection. Cell Host Microbe 24, 296–307. e7.
Jeong, S., Kim, H.Y., Kim, A.R., Yun, C.H., and Han, S.H. 2019. Propionate ameliorates Staphylococcus aureus skin infection by attenuating bacterial growth. Front. Microbiol. 10, 1363.
Kim, J.H., Kim, Y., Shin, S.J., Park, J.W., and Jung, I.Y. 2010. Tooth discoloration of immature permanent incisor associated with triple antibiotic therapy: A case report. J. Endod. 36, 1086–1091.
Kirchhoff, A.L., Raldi, D.P., Salles, A.C., Cunha, R.S., and Mello, I. 2015. Tooth discolouration and internal bleaching after the use of triple antibiotic paste. Int. Endod. J. 48, 1181–1187.
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., and Backhed, F. 2016. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345.
Lin, Y.H., Mickel, A.K., and Chogle, S. 2003. Effectiveness of selected materials against Enterococcus faecalis: Part 3. The antibacterial effect of calcium hydroxide and chlorhexidine on Enterococcus faecalis. J. Endod. 29, 565–566.
Lobritz, M.A., Belenky, P., Porter, C.B., Gutierrez, A., Yang, J.H., Schwarz, E.G., Dwyer, D.J., Khalil, A.S., and Collins, J.J. 2015. Antibiotic efficacy is linked to bacterial cellular respiration. Proc. Natl. Acad. Sci. USA 112, 8173–8180.
Maruyama, K. and Kitamura, H. 1985. Mechanisms of growth inhibition by propionate and restoration of the growth by sodium bicarbonate or acetate in Rhodopseudomonas sphaeroides. J. Biochem. 98, 819–824.
McHugh, C.P., Zhang, P., Michalek, S., and Eleazer, P.D. 2004. pH required to kill Enterococcus faecalis in vitro. J. Endod. 30, 218–219.
Miller, W.R., Munita, J.M., and Arias, C.A. 2014. Mechanisms of antibiotic resistance in enterococci. Expert. Rev. Anti. Infect. Ther. 12, 1221–1236.
Mohammadi, Z. 2008. Chlorhexidine gluconate, its properties and applications in endodontics. Iran Endod. J. 2, 113–125.
Pemberton, M.N. 2016. Allergy to chlorhexidine. Dent. Update 43, 272–274.
Rakita, R.M., Vanek, N.N., Jacques-Palaz, K., Mee, M., Mariscalco, M.M., Dunny, G.M., Snuggs, M., Van Winkle, W.B., and Simon, S.I. 1999. Enterococcus faecalis bearing aggregation substance is resistant to killing by human neutrophils despite phagocytosis and neutrophil activation. Infect. Immun. 67, 6067–6075.
Rocco, C.J. and Escalante-Semerena, J.C. 2010. In Salmonella enterica, 2-methylcitrate blocks gluconeogenesis. J. Bacteriol. 192, 771–778.
Roe, A.J., O’Byrne, C., McLaggan, D., and Booth, I.R. 2002. Inhibition of Escherichia coli growth by acetic acid: A problem with methionine biosynthesis and homocysteine toxicity. Microbiology 148, 2215–2222.
Siqueira, J.F. Jr. and Rocas, I.N. 2004. Polymerase chain reaction-based analysis of microorganisms associated with failed endodontic treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 97, 85–94.
Stuart, C.H., Schwartz, S.A., Beeson, T.J., and Owatz, C.B. 2006. Enterococcus faecalis: Its role in root canal treatment failure and current concepts in retreatment. J. Endod. 32, 93–98.
Tendolkar, P.M., Baghdayan, A.S., and Shankar, N. 2003. Pathogenic Enterococci: New developments in the 21st century. Cell. Mol. Life Sci. 60, 2622–2636.
Vijayaraghavan, R., Mathian, V.M., Sundaram, A.M., Karunakaran, R., and Vinodh, S. 2012. Triple antibiotic paste in root canal therapy. J. Pharm. Bioallied Sci. 4, S230–233.
Yonezawa, H., Osaki, T., Hanawa, T., Kurata, S., Zaman, C., Woo, T.D., Takahashi, M., Matsubara, S., Kawakami, H., Ochiai, K., et al. 2012. Destructive effects of butyrate on the cell envelope of Helicobacter pylori. J. Med. Microbiol. 61, 582–589.
Zimmermann, G.R., Lehar, J., and Keith, C.T. 2007. Multi-target therapeutics: When the whole is greater than the sum of the parts. Drug Discov. Today 12, 34–42.
Zorko, M. and Jerala, R. 2008. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. J. Antimicrob. Chemother. 62, 730–737.
Acknowledgements
We thank the Korean Collection for Oral Microbiology and Korean Agricultural Culture Collection for kindly providing Enterococcal strains. This work was supported by grants from the National Research Foundation of Korea, which is funded by the Korean government (NRF-2019R1A2C2007041 and NRF-2018R1A5A2024418) and by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (HI17C1377), Republic of Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors deny any conflicts of interest related to this study.
Rights and permissions
About this article
Cite this article
Jeong, S., Lee, Y., Yun, CH. et al. Propionate, together with triple antibiotics, inhibits the growth of Enterococci. J Microbiol. 57, 1019–1024 (2019). https://doi.org/10.1007/s12275-019-9434-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-019-9434-7